Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma
Clinical trial NCT07543510 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07543510
- Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-08-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.